Computational Identification of Natural Product–Based Aryl Hydrocarbon Receptor Modulators for Psoriasis Therapy

سال انتشار: 1405
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 11

فایل این مقاله در 15 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_CHM-10-4_008

تاریخ نمایه سازی: 9 اسفند 1404

چکیده مقاله:

Psoriasis is a chronic inflammatory disease of the skin that needs to be managed in the long term, and the aryl hydrocarbon receptor (AhR) has turned out to be an effective therapeutic target because of its ability to control keratinocyte differentiation and immune signaling. Based on the approved pharmacophore template named Tapinarof, a pharmacophore model was used to screen the ZINC Natural Products Library to identify alternative scaffolds. Three of them, ZINC۶۹۴۸۲۱۰۳ (-۱۱.۱۳۲ kcal/mol), ZINC۴۰۹۸۶۳۹ (-۱۱.۰۰۸ kcal/mol), and ZINC۱۳۴۸۵۰۹۳ (-۱۰.۹۰۹ kcal/mol)), more strongly predicted binding to the AhR PAS-B domain than Tapinarof (-۱۰.۲۰۹ kcal/mol). These molecules also replicate the important aromatic stacking and hydrogen-bond interactions that are significant in the modulation of AhR. The molecular mechanics/generalized Boron surface area (MM-GBSA) analysis also confirmed their high binding potential with ZINC۶۹۴۸۲۱۰۳, presenting a favorable ΔGbind value. Simulations of ۱۰۰ ns using molecular dynamics (MD) ensured the stability of the interaction between the ligands and proteins, remaining at constant values of Root Mean Square Deviation (RMSD), and the contact profile was maintained during the simulation. Drug-likeness and bioavailability assessments with ADMETlab showed that all three compounds were within reasonable physicochemical ranges, with ZINC۱۳۴۸۵۰۹۳ exhibiting the most moderate ADMET parameters. In general, the results identified three natural product scaffolds as potential candidates for the development of next-generation AhR modulators for the treatment of psoriasis, particularly ZINC۶۹۴۸۲۱۰۳ and ZINC۱۳۴۸۵۰۹۳. Their therapeutic potential should be validated through further experiments.

نویسندگان

Konatham Teja Kumar Reddy

Department of Pharmaceutical Analysis, Malla Reddy Institute of Pharmaceutical Sciences, Malla Reddy Vishwavidyapeeth (Deemed to be University), Secunderabad, ۵۰۰۱۰۰, Telangana, India

G. Surendra

School of Pharmacy, ITM University, Turari Campus, Jhansi Road, Gwalior, Madhya Pradesh, India

E. Joel Mart

Department of Pharmacology, Vels Institute of Science, Technology and Advanced Studies (VISTAS), PV Vaithiyalingam Rd, Velan Nagar, Krishnapuram, Pallavaram, Chennai, Tamil Nadu ۶۰۰۱۱۷, India

Ramenani Hari Babu

Department of Pharmacy Practice, Teerthanker Mahaveer College of Pharmacy, Teerthanker Mahaveer University, Moradabad ۲۴۴۰۰۱, India

Mohamed Shiek Arabath S.A.

Department of Pharmacognosy, Arulmigu Kalasalingam College of Pharmacy, Krishnankoil Tamil Nadu, India

Phanindra Erukulla

Department of Regulatory Affairs, Ricon Pharma LLC, ۱۰۰ Ford Rd, Suite ۹, Denville, NJ ۰۷۸۳۴, USA

Krishna Vamsi Kandimalla

Department of Regulatory Affairs, InvaGen Pharmaceuticals, A Cipla subsidiary, ۵۵۰ South Research Place, Central Islip, USA

Pericharla Venkata Narasimha Raju Narasimha Raju

Department of Regulatory Affairs, Hikma Pharmaceuticals USA, Inc.,۲ Esterbrook Lane, Cherry Hill, NJ ۰۸۰۰۳, USA

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Boehncke, W.-H., Schön, M.P. Psoriasis. The Lancet, ۲۰۱۵, ۳۸۶(۹۹۹۷), ۹۸۳-۹۹۴ ...
  • Rapp, S.R., Feldman, S.R., Exum, M.L., Fleischer Jr, A.B., Reboussin, ...
  • Soumya, P., Vignanandam, S., Aishwarya, B., Saniya, S., Sofi, S., ...
  • Damiani, G., Bragazzi, N.L., Karimkhani Aksut, C., Wu, D., Alicandro, ...
  • Raharja, A., Mahil, S.K., Barker, J.N. Psoriasis: A brief overview. ...
  • Feldman, S.R., Goffe, B., Rice, G., Mitchell, M., Kaur, M., ...
  • Bissonnette, R., Gold, L.S., Rubenstein, D.S., Tallman, A.M., Armstrong, A. ...
  • Lin, X., Meng, X., Lin, J. The role of aryl ...
  • Guo, J., Zhang, H., Lin, W., Lu, L., Su, J., ...
  • Lin, X., Meng, X., Lin, J. The role of aryl ...
  • Silverberg, J.I., Boguniewicz, M., Quintana, F.J., Clark, R.A., Gross, L., ...
  • Haarmann-Stemmann, T., Sutter, T.R., Krutmann, J., Esser, C. The mode ...
  • Jaleel, N., Navya, V., George, M. Tapinarof: A novel topical ...
  • Smith, S.H., Jayawickreme, C., Rickard, D.J., Nicodeme, E., Bui, T., ...
  • Eichenfield, L.F., Silverberg, J.I., Hebert, A.A., Chovatiya, R., Brown, P.M., ...
  • Armstrong, A.W., Blauvelt, A., Duffin, K.C., Huang, Y.H., Savage, L.J., ...
  • Di Meglio, P., Duarte, J.H., Ahlfors, H., Owens, N.D., Li, ...
  • Sá Justo, K., Zonzini Filho, F. Impact of treatment adherence ...
  • Yélamos, O., Ros, S., Puig, L. Improving patient outcomes in ...
  • Jadhav, S., Dighe, P. In vitro evaluation, and molecular docking ...
  • Ban, T., Ohue, M., Akiyama, Y. Multiple grid arrangement improves ...
  • Khan, A., Unnisa, A., Sohel, M., Date, M., Panpaliya, N., ...
  • Khan, S.L., Siddiqui, F.A., Shaikh, M.S., Nema, N.V., Shaikh, A.A. ...
  • Dasmahapatra, U., Kumar, C.K., Das, S., Subramanian, P.T., Murali, P., ...
  • Alanazi, A., Younas, S., Khan, M.U., Saleem, H., Alruwaili, M., ...
  • Joshi, M., Pathan, I., Sahu, A., Raza, A., Sahu, Y., ...
  • Fakola, E.G., Sarkar, A., Uttarkar, A., Bhattacharya, S., Choudhury, S., ...
  • Halder, S.K., Sultana, I., Shuvo, M.N., Shil, A., Himel, M.K., ...
  • Xiong, G., Wu, Z., Yi, J., Fu, L., Yang, Z., ...
  • Siddiqui, F., Bakshi, V. Hydroalcoholic Extraction, Phytoconstituent Profiling by LC-HRMS, ...
  • Vikhe, S.R., Patil, S., Ghogare, R., Madkhali, H.A., Khan, M.M.U., ...
  • Muralidharan, V., Sachdeo, R.A., Singh, L.P., Haque, M., Panigrahy, U., ...
  • نمایش کامل مراجع